Cargando…

Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Gualberto, A, Hixon, M L, Karp, D D, Li, D, Green, S, Dolled-Filhart, M, Paz-Ares, L G, Novello, S, Blakely, J, Langer, C J, Pollak, M N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516686/ https://www.ncbi.nlm.nih.gov/pubmed/23211971 http://dx.doi.org/10.1038/bjc.2012.497

Ejemplares similares

Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
por: Gualberto, A, et al.
Publicado: (2011)

Reply: ‘Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab’
por: Gualberto, A, et al.
Publicado: (2011)

Comment on ‘Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab’
por: Shimokawa, H, et al.
Publicado: (2011)

Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC
por: Cao, Hongxin, et al.
Publicado: (2016)

Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy
por: Qu, Xiao, et al.
Publicado: (2017)

Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma
por: Zhang, Tiehong, et al.
Publicado: (2014)

Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer
por: Cao, Hongxin, et al.
Publicado: (2015)

Quantitative Assessment of Tissue Biomarkers and Construction of a Model to Predict Outcome in Breast Cancer Using Multiple Imputation
por: Emerson, John W., et al.
Publicado: (2008)

The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study
por: Molife, L R, et al.
Publicado: (2010)

Retracted: Study on the Predictive Value of P53 Protein Expression in Brain Metastasis in NSCLC and the Mechanism of miR-424 Reversing Platinum Resistance in NSCLC
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Retracted: The Value of Serum Exosomal miR-184 in the Diagnosis of NSCLC
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Synergistic Effect of Stereotactic Radiotherapy Combined with Karelizumab on Patients with Advanced NSCLC
por: Engineering, Journal of Healthcare
Publicado: (2023)

Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer
por: Goto, Yasushi, et al.
Publicado: (2011)

Retracted: Value of CT Radiomics and Clinical Features in Predicting Bone Metastases in Patients with NSCLC
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

MicroRNA-432 inhibits the aggressiveness of glioblastoma multiforme by directly targeting IGF-1R
por: Chen, Xudong, et al.
Publicado: (2022)

MicroRNA-186 targets IGF-1R and exerts tumor-suppressing functions in glioma
por: Jiang, Jian, et al.
Publicado: (2022)

Computational and Bioinformatics Frameworks for Next-Generation Whole Exome and Genome Sequencing
por: Dolled-Filhart, Marisa P., et al.
Publicado: (2013)

Retracted: Study on PD-L1 Expression in NSCLC Patients and Related Influencing Factors in the Real World
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R
por: Li, Jieyan, et al.
Publicado: (2022)

MicroRNA-302a inhibits osteosarcoma cell migration and invasion by directly targeting IGF-1R
por: Zhang, Chunhong, et al.
Publicado: (2022)

Retraction: Regulation of Proapoptotic Mammalian ste20–Like Kinase MST2 by the IGF1-Akt Pathway
Publicado: (2023)

Matrine Suppresses the Migration and Invasion of NSCLC Cells by Inhibiting PAX2-Induced Epithelial-Mesenchymal Transition [Retraction]
Publicado: (2023)

microRNA-628 Inhibits the Proliferation of Acute Myeloid Leukemia Cells by Directly Targeting IGF-1R [Retraction]
Publicado: (2021)

Osseointegration of Layer-by-Layer Polyelectrolyte Multilayers Loaded with IGF1 and Coated on Titanium Implant Under Osteoporotic Condition [Retraction]
Publicado: (2021)

microRNA-188 acts as a tumour suppressor in glioma by directly targeting the IGF2BP2 gene
por: Ding, Li, et al.
Publicado: (2022)

Retracted: IGF-1 Promotes Epithelial-Mesenchymal Transition of Lens Epithelial Cells That Is Conferred by miR-3666 Loss
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Retraction: Up-Regulation of Sonic Hedgehog Contributes to TGF-β1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells
Publicado: (2018)

Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: Relationship between PLR and Clinicopathological Characteristics of Patients with Advanced NSCLC and Its Predictive Value for the Efficacy of Chemotherapy and Prognosis
por: International, Emergency Medicine
Publicado: (2023)

MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1
por: Wang, Ping, et al.
Publicado: (2022)

CircASXL1 Knockdown Restrains Hypoxia-Induced DDP Resistance and NSCLC Progression by Sponging miR-206 [Retraction]
Publicado: (2022)

[Retracted] Inhibition of microRNA‑19b promotes ovarian granulosa cell proliferation by targeting IGF‑1 in polycystic ovary syndrome
por: Zhong, Zhuohui, et al.
Publicado: (2023)

Durvalumab in NSCLC: latest evidence and clinical potential
por: Muñoz-Unceta, Nerea, et al.
Publicado: (2018)

Retracted: High Expression of PTGR1 Promotes NSCLC Cell Growth via Positive Regulation of Cyclin-Dependent Protein Kinase Complex
por: BioMed Research International,
Publicado: (2017)

Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1
por: Cheng, Ruirui, et al.
Publicado: (2022)

Retracted: Integrative Nomogram of Computed Tomography Radiomics, Clinical, and Tumor Immune Features for Analysis of Disease-Free Survival of NSCLC Patients with Surgery
por: Oncology, Journal of
Publicado: (2023)

Retracted: The Expression of hnRNP A2/B1 in Benign and Malignant Lung Lesions and Its Early Diagnosis Value in NSCLC
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Retraction: Proline-Rich Tyrosine Kinase 2 (Pyk2) Regulates IGF-I-Induced Cell Motility and Invasion of Urothelial Carcinoma Cells
Publicado: (2019)

[Retracted] MicroRNA‑877 inhibits cell proliferation and invasion in non‑small cell lung cancer by directly targeting IGF‑1R
por: Zhou, Guohua, et al.
Publicado: (2022)

Retraction Notice to: MTTL3 upregulates microRNA-1246 to promote occurrence and progression of NSCLC via targeting paternally expressed gene 3
por: Huang, Shaohong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jp3k691rtelnsoun008075d9hh